Usefulness of troponin levels below the diagnostic cut-off level for acute myocardial infarction in predicting prognosis in unselected patients admitted to the coronary care unit

被引:9
作者
Agewall, Stefan [1 ]
Olsson, Tobias
Lowbeer, Christian
机构
[1] Univ Oslo, Aker Univ Hosp, Div Cardiol, N-0316 Oslo, Norway
[2] Karolinska UnivHosp, Karolinska Inst, Dept Lab Med, Div Cardiol, Stockholm, Sweden
[3] Karolinska UnivHosp, Karolinska Inst, Dept Lab Med, Div Clin Chem, Stockholm, Sweden
[4] Aleris Medilab, Stockholm, Sweden
关键词
D O I
10.1016/j.amjcard.2006.12.059
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study evaluated the prognosis at different troponin concentrations regardless of the underlying diagnosis in an unselected group of patients admitted to the coronary care unit (CCU) and whether the prognosis is dependent on the cause of the troponin increase. Troponin I was measured with the Stratus CS analyzer (Dade Behring) in 468 consecutively and unselected patients admitted to the CCU at Karolinska University Hospital with possible myocardial ischemia lasting < 12 hours before arrival. A troponin I concentration below (0.02 to 0.10 mu g/L) the diagnostic cut-off level for myocardial infarction predicted mortality after 40 months. In patients with a troponin I level above the diagnostic cut-off level for acute myocardial infarction, the underlying cause of the troponin increase did not affect the prognosis. In conclusion, we report that a troponin I increase below the new cut-off level for myocardial necrosis was associated with increased mortality in unselected patients with possible myocardial ischemia admitted to the CCU at a university hospital. We also observed that the underlying cause of the troponin increase appears to be less important for outcome. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1357 / 1359
页数:3
相关论文
共 7 条
  • [1] Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction
    Alpert, JS
    Antman, E
    Apple, F
    Armstrong, PW
    Bassand, JP
    de Luna, AB
    Beller, G
    Breithardt, G
    Chaitman, BR
    Clemmensen, P
    Falk, E
    Fishbein, MC
    Galvani, M
    Garson, A
    Grines, C
    Hamm, C
    Jaffe, A
    Katus, H
    Kjekshus, J
    Klein, W
    Klootwijk, P
    Lenfant, C
    Levy, D
    Levy, RI
    Luepker, R
    Marcus, F
    Näslund, U
    Ohman, M
    Pahlm, O
    Poole-Wilson, P
    Popp, R
    Alto, P
    Pyörälä, K
    Ravkilde, J
    Rehnquist, N
    Roberts, W
    Roberts, R
    Roelandt, J
    Rydén, L
    Sans, S
    Simoons, ML
    Thygesen, K
    Tunstall-Pedoe, H
    Underwood, R
    Uretsky, BF
    Van de Werf, F
    Voipio-Pulkki, LM
    Wagner, G
    Wallentin, L
    Wijns, W
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) : 959 - 969
  • [2] Altinier S, 2000, CLIN CHEM, V46, P991
  • [3] Cardiac troponin I in patients with severe exacerbation of chronic obstructive pulmonary disease
    Baillard, C
    Boussarsar, M
    Fosse, JP
    Girou, E
    Le Toumelin, P
    Cracco, C
    Jaber, S
    Cohen, Y
    Brochard, L
    [J]. INTENSIVE CARE MEDICINE, 2003, 29 (04) : 584 - 589
  • [4] Higgins JP, 2003, CLIN INVEST MED, V26, P133
  • [5] Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure
    Horwich, TB
    Patel, J
    MacLellan, WR
    Fonarow, GC
    [J]. CIRCULATION, 2003, 108 (07) : 833 - 838
  • [6] Evaluation of imprecision for cardiac troponin assays at low-range concentrations
    Panteghini, M
    Pagani, F
    Yeo, KTJ
    Apple, FS
    Christenson, RH
    Dati, F
    Mair, J
    Ravkilde, J
    Wu, AHB
    [J]. CLINICAL CHEMISTRY, 2004, 50 (02) : 327 - 332
  • [7] Serum cardiac troponin T as a prognostic marker in early sepsis
    Spies, C
    Haude, V
    Fitzner, R
    Schröder, K
    Overbeck, M
    Runkel, N
    Schaffartzik, W
    [J]. CHEST, 1998, 113 (04) : 1055 - 1063